OVID
Ovid Therapeutics Inc
2.40$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,221.1% | -8,389.0% | -11,274.3% | -8,434.9% | -8,674.6% | -13,168.4% | -7,907.7% | -76.1% | -9,751.5% | -1,449.6% | – | -2,400.3% | -3,460.1% | |
| 369.2% | 282.7% | 91.9% | 87.6% | 97.7% | 193.4% | 108.5% | 1.6% | 12.9% | 2.4% | – | 2.2% | 5.4% | |
| 1,496.4% | 1,259.9% | 1,329.7% | 1,029.6% | 756.1% | 1,657.9% | 987.7% | 19.4% | 840.2% | 166.4% | – | 195.2% | 302.0% | |
| 26.6% | 2,572.8% | -1,175.7% | 2,478.1% | -1,008.7% | -1,122.4% | -1,002.3% | -19.8% | -1,281.1% | 18.7% | – | -290.2% | -85.4% | |
| 4.8% | 0.9% | 12.8% | 20.1% | 2.3% | 28.9% | 16.9% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | |
| -3,999.4% | -34,166.3% | 13,640.5% | 7,587.0% | 168.8% | 28,015.8% | 3,924.6% | 192.2% | 3,828.0% | -10,036.5% | – | -11,833.6% | -9,336.6% | |
| – | -10,879,461.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 205.2% | 21,150.3% | 154.1% | 210.7% | 22.0% | 0.0% | 10.0% | 0.0% | 11.4% | 10,470.6% | – | 2,946.9% | 11,735.8% | |
| -13,015.3% | -21,405.0% | 2,520.6% | -637.9% | -8,483.8% | 14,847.4% | -3,973.1% | 116.1% | -5,912.1% | -1,038.7% | – | -11,287.4% | -1,079.5% | |
| -9,225.9% | -8,389.8% | -11,287.2% | -8,455.0% | -8,672.3% | -13,197.4% | -7,907.7% | -76.1% | -9,751.5% | -1,449.6% | – | -2,400.3% | -3,460.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.